Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Modeling HIV infection, treatment, rebound, and intervention in human immune organoids.
Journal: bioRxiv : the preprint server for biology
Published: February 09, 2026
NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.
Journal: Nature communications
Published: October 28, 2025
Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression.
Journal: Immunity & inflammation
Published: June 21, 2025
Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns.
Journal: Nature communications
Published: May 30, 2024
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells.
Journal: Pathogens & immunity
Published: January 31, 2024
Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection.
Journal: Microorganisms
Published: May 30, 2023
A humanized mouse model to study NK cell biology during HIV infection.
Journal: The Journal of clinical investigation
Published: December 15, 2022
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal.
Journal: Virology
Published: November 08, 2022
Latency reversal plus natural killer cells diminish HIV reservoir in vivo.
Journal: Nature communications
Published: October 14, 2021
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.
Journal: Stem cell research & therapy
Published: August 23, 2021
Last Updated: 09/26/2026